K222379: Alinity m STI Assay (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K222379 (Alinity m STI Assay, cleared 2023-03-03 for Abbott Molecular, Inc.) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K222379
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK222379
Cleared Device Trade / Generic NameAlinity m STI Assay
FDA Applicant on FilingAbbott Molecular, Inc.
FDA 3-Letter Product ClassificationProduct Code QEP
FDA Substantial Equivalence Decision Date2023-03-03
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Abbott Laboratories across sibling Meru public-data platforms.

Inspect consolidated manufacturer lineage at Abbott Molecular, Inc., compare peer devices under FDA Product Code QEP, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.